Atalanta Sosnoff Capital LLC Has $45.35 Million Stake in UnitedHealth Group Incorporated $UNH

Key Points

• Atalanta Sosnoff Capital LLC decreased its stake in UnitedHealth Group by 4.1%, owning 86,590 shares valued at approximately $45.35 million after selling 3,669 shares in the first quarter.
• Several analysts have provided mixed ratings for UnitedHealth Group, with a consensus rating of "Moderate Buy" and a price target averaging $353.00.
• UnitedHealth Group recently declared a quarterly dividend of $2.21 per share, reflecting an annual yield of 2.9%, with the ex-dividend date set for September 15th.

Atalanta Sosnoff Capital LLC trimmed its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 4.1% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 86,590 shares of the healthcare conglomerate's stock after selling 3,669 shares during the period. Atalanta Sosnoff Capital LLC's holdings in UnitedHealth Group were worth $45,351,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of UNH. Vanguard Group Inc. grew its holdings in shares of UnitedHealth Group by 6.6% during the first quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock worth $47,519,620,000 after purchasing an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP grew its holdings in shares of UnitedHealth Group by 10.6% during the first quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock worth $13,537,859,000 after purchasing an additional 2,486,839 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in shares of UnitedHealth Group by 36.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 8,592,718 shares of the healthcare conglomerate's stock worth $4,346,712,000 after purchasing an additional 2,301,010 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of UnitedHealth Group by 56,142.1% during the first quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock worth $4,344,586,000 after purchasing an additional 8,280,404 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its holdings in shares of UnitedHealth Group by 2.5% during the first quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock worth $4,257,131,000 after purchasing an additional 196,696 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors.

Insider Activity

In other news, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 0.28% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on UNH shares. Wells Fargo & Company cut their price target on UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a research note on Monday, August 4th. Bank of America upped their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research note on Monday, August 18th. Mizuho cut their target price on UnitedHealth Group from $515.00 to $350.00 and set an "outperform" rating on the stock in a research note on Friday, May 16th. Robert W. Baird reissued an "underperform" rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Finally, KeyCorp cut their target price on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have given a Sell rating to the company's stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $354.86.

UnitedHealth Group Trading Up 1.5%

Shares of UnitedHealth Group stock traded up $4.72 during trading hours on Friday, hitting $315.10. The company's stock had a trading volume of 14,093,579 shares, compared to its average volume of 17,031,034. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market capitalization of $285.38 billion, a PE ratio of 13.65, a price-to-earnings-growth ratio of 2.00 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The stock has a 50 day moving average of $288.78 and a 200 day moving average of $374.41.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.